CML | opacc

FDA Approval of Bosulif Adds to Toolkit of Treatment Options for Children With CML

The Food and Drug Administration (FDA) has approved Bosulif (bosutinib) for the treatment of children as young as 1 year old with newly...

FDA approves dasatinib for children with Philadelphia chromosome-positive chronic myeloid leukemia

The FDA expanded the indication for dasatinib to include the treatment of children with Philadelphia chromosome-positive chronic myeloid...

FDA Grants Orphan Drug Designation to Opaganib in Neuroblastoma

After my daughter's cancer, I wanted to control her entire life. Then she went to college.

When Childhood Cancer Survivors Face Sexual Challenges

Early interventions may improve long-term academic achievement in young childhood brain tumor survivors

Immunotherapy for children with primary liver carcinomas: Research offers new hope

Pediatric psychologist explains how to support your child's development after a cancer diagnosis

Adult Survivors of Childhood Cancer Have High Prevalence of Chronic Pain

Spontaneous Remission in Childhood Cancer Rare but Fleeting

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition

Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma